A clinical overview of non‐alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications—what the non‐specialist needs to know

MD Muthiah, N Cheng Han… - Diabetes, Obesity and …, 2022 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) has a rapidly rising prevalence worldwide and is
the most common cause of liver disease in developed countries. In this article, we discuss …

Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases

J Cai, XJ Zhang, YX Ji, P Zhang, ZG She… - Circulation research, 2020 - Am Heart Assoc
Cardiovascular diseases (CVDs) remain a leading cause of death worldwide. Among the
major risk factors for CVD, obesity and diabetes mellitus have received considerable …

Aerobic exercise in the management of metabolic dysfunction associated fatty liver disease

MV Machado - Diabetes, Metabolic Syndrome and Obesity, 2021 - Taylor & Francis
Sedentarism is the pandemic of modern times. It is associated with several medical
conditions including obesity, type 2 diabetes mellitus, cardiovascular diseases and also liver …

Exercise in the management of metabolic-associated fatty liver disease (MAFLD) in adults: A position statement from exercise and sport science Australia

SE Keating, A Sabag, K Hallsworth, IJ Hickman… - Sports Medicine, 2023 - Springer
Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis

JN Yong, CH Ng, CWM Lee, YY Chan, ASP Tang… - Hepatology …, 2022 - Springer
Objective Several studies have documented a relationship between non-alcoholic fatty liver
disease (NAFLD) and structural heart disease, particularly diastolic function. This meta …

Current management of non‐alcoholic steatohepatitis

MD Muthiah, AJ Sanyal - Liver International, 2020 - Wiley Online Library
Non‐alcoholic steatohepatitis (NASH) is the most common cause of liver disease in Western
populations, and its prevalence is increasing rapidly. It is part of a multisystem disease …

Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction

A Miller, J McNamara, SL Hummel, MC Konerman… - Scientific reports, 2020 - nature.com
Insulin resistance and altered energy metabolism is common in non-alcoholic fatty liver
disease (NAFLD) and appears to also be associated with myocardial dysfunction. We aimed …

MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease

MM Ruissen, AL Mak, U Beuers… - European journal of …, 2020 - academic.oup.com
Non-alcoholic fatty liver disease (NAFLD) is a growing health problem with a global
prevalence of over 25% and prevalence rates of over 60% in high-risk populations. It is …

PCSK9, a promising novel target for age-related cardiovascular dysfunction

C Matyas, E Trojnar, S Zhao, M Arif… - Basic to Translational …, 2023 - jacc.org
Cardiovascular diseases (CVDs) are the leading cause of death among elderly people.
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an important regulator of …

High-intensity interval training is safe, feasible and efficacious in nonalcoholic steatohepatitis: a randomized controlled trial

SE Keating, I Croci, MP Wallen, ER Cox… - Digestive Diseases and …, 2023 - Springer
Abstract Background High-Intensity Interval Training (HIIT) involves bursts of high-intensity
exercise interspersed with lower-intensity exercise recovery. HIIT may benefit …